Lilly Stock Jumps After Phase 3 Weight-Drug Readout
Lilly stock jumps after Phase 3 readout for a next-generation weight-loss drug exceeded expectations. Investors see d...
Find clear guidance on which blue chip coin to start with, including risk notes and a simple starter approach for newcomers.
22,235 articlesLilly stock jumps after Phase 3 readout for a next-generation weight-loss drug exceeded expectations. Investors see d...
As of June 2026, households pursue financial independence by targeting $7,500 a month in dividend income to replace a...
Equity Residential and AvalonBay Communities have named the leadership slate for their planned all-stock merger, sign...
Pi Network faces another potential delay as it advances Protocol 25. The June 18 deadline could be missed, echoing pa...
As rate pressure persists, INDS faces mixed signals from its industrial and self-storage holdings. This dividend safe...
With inflation stubborn and growth resilient, traders are debating whether the Fed will hold rates in June or pivot l...
A security researcher leveraged Claude-powered tooling to reveal a long-standing vulnerability in Zcash's Orchard cir...
New CPI data renews tensions between Trump’s White House and Fed Chair Warsh, signaling a potential policy clash as i...
A new Fidelity study finds a majority of Americans foresee steep medical bills in retirement, prompting families to s...
The White House has nominated Brian Johnson to head the CFPB, aiming to steer consumer protection policy as leadershi...
SpaceX IPO buzz is rising, but the hype can mislead older investors. A new market briefing outlines the risks and pra...
Retirees face a surprising two-year lag between last-year earnings and Medicare premium changes, even when Social Sec...